SCHEMBL24850792

SCHEMBL24850792

CNC(=O)C(C)(C)CCCCCCN

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAOX Q6QHF9 4/20 0.39
FDPS P14324 2/20 0.38
ACLY P53396 1/20 0.37
ACACB O00763 1/20 0.36
ACACA Q13085 1/20 0.36
ALOX15 P16050 2/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
PLG P00747 1/20 0.35
LMNA P02545 1/20 0.35
THRB P10828 1/20 0.35
SLC6A2 P23975 1/20 0.35
RECQL P46063 1/20 0.35
SLC6A3 Q01959 1/20 0.35
KMT2A Q03164 1/20 0.35
CCR2 P41597 2/20 0.35
CCR1 P32246 1/20 0.35
CCR5 P51681 1/20 0.35
CXCR4 P61073 1/20 0.35
MAOA P21397 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15001263 0.85 MEN1 (0.32) FDPSMEN1LMNAKMT2AKDM4E
SCHEMBL23812164 0.82 CCR2 (0.48) FDPSALOX15CCR2CCR1CCR5
SCHEMBL8632431 0.79 CCR2 (0.46) FDPSALOX15CCR2CCR1CCR5
SCHEMBL12064065 0.78 ALDH1A1 (0.34) ACLYACACBACACAALOX15ALDH1A1
SCHEMBL28439734 0.77 ACLY (0.61) PAOXFDPSACLYACACBACACA
SCHEMBL4638149 0.77 CCR2 (0.40) FDPSALOX15MEN1ALDH1A1KMT2A
SCHEMBL10870280 0.77 ACLY (0.61) PAOXFDPSACLYACACBACACA
SCHEMBL10870768 0.77 ACLY (0.61) PAOXFDPSACLYACACBACACA
SCHEMBL10869894 0.77 ACLY (0.61) PAOXFDPSACLYACACBACACA
SCHEMBL9350070 0.77 ACLY (0.61) PAOXFDPSACLYACACBACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. 2023-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES PADI4, PADI2, PADI1 PAOX 499/4885FDPS 1037/4885ACLY 1014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.